DOXORUBICIN HYDROCHLORIDE | A203263 | SUN PHARMACEUTICAL INDUSTRIES LTD
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition From Greenblum & Bernstein, P.L.C. FDA-2014-P-0210 · 3 docket documents Greenblum & Bernstein, P.L.C. filed this petition on behalf of its client on February 11, 2014, under section 505(j) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA either withdraw the designation of ANDA #203263 for doxorubicin hydrochloride (liposomal) injection as the Referenc | 505(q) | 2014-03-04 | Withdrawn | Greenblum & Bernstein, P.L.C. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.